Re: Things are happening
|
|
Resverlogix Corp.
|
Aug 03, 2018 04:28PM
|
What If - Uses of Apabetalone
|
2
|
Resverlogix Corp.
|
Aug 11, 2018 02:52PM
|
Re: New Zacks SCR report "Apabetalone: A Potential Alzheimer's Play?"
|
4
|
Resverlogix Corp.
|
Aug 24, 2018 02:39PM
|
Re: ABCA1 overexpression worsens colorectal cancer prognosis and this can be ameliorated by apabetalone
|
4
|
Resverlogix Corp.
|
Aug 24, 2018 02:53PM
|
My Current Wish List
|
3
|
Resverlogix Corp.
|
Aug 27, 2018 03:44PM
|
Re: Blistering volume today
|
2
|
Resverlogix Corp.
|
Aug 30, 2018 03:01PM
|
Re: Blistering volume today
|
2
|
Resverlogix Corp.
|
Aug 31, 2018 03:45PM
|
Re: Zenith MD&A posted to SEDAR 8/23/18
|
1
|
Zenith Epigenetics
|
Sep 01, 2018 01:23PM
|
Re: Two more clinical study sites added to the ZEN-3694/enzalutamid... mCRPC trial
|
6
|
Zenith Epigenetics
|
Sep 05, 2018 03:50PM
|
Epigenetics in the Sept 8th Globe and Mail
|
4
|
Zenith Epigenetics
|
Sep 10, 2018 02:07PM
|
Re: Zenith AGM webcast 9/12/2018
|
4
|
Zenith Epigenetics
|
Sep 11, 2018 04:51PM
|
Re: From the floor at AGM
|
3
|
Resverlogix Corp.
|
Sep 13, 2018 12:22PM
|
Re: RVX_2018_09_12_Trans...
|
3
|
Resverlogix Corp.
|
Sep 18, 2018 02:36PM
|
Re: (one) case study
|
5
|
Zenith Epigenetics
|
Oct 03, 2018 06:39PM
|
Re: tiny volume
|
4
|
Resverlogix Corp.
|
Oct 04, 2018 10:22AM
|
Re: Billionaire Ken Dart plans to donate Wairoa Gorge Bike Park
|
3
|
Resverlogix Corp.
|
Oct 15, 2018 01:27PM
|
Re: Endocyte Valuation
|
2
|
Zenith Epigenetics
|
Oct 19, 2018 01:00PM
|
Re: So what is upcoming that can hopefully affect the price,...
|
4
|
Resverlogix Corp.
|
Oct 24, 2018 11:12AM
|
Re: ... unfinished business
|
4
|
Zenith Epigenetics
|
Oct 25, 2018 11:38AM
|
Re: ... unfinished business
|
3
|
Zenith Epigenetics
|
Oct 31, 2018 02:39PM
|